Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2003
04/16/2003EP1301517A1 Thienopyrrolidinones
04/16/2003EP1301516A1 Modulators of protein tyrosine phosphatases (ptpases)
04/16/2003EP1301514A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use
04/16/2003EP1301511A2 IMIDAZO 1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
04/16/2003EP1301510A1 New bispidine compounds and their use in the treatment of cardiac arrhythmias
04/16/2003EP1301508A1 Novel processes for the preparation of 4-phenylpiperidine derivatives
04/16/2003EP1301507A2 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
04/16/2003EP1301506A1 Cyclic amino acid derivatives
04/16/2003EP1301505A2 Thiophene retinoids
04/16/2003EP1301503A1 Coumarin derivatives with comt inhibiting activity
04/16/2003EP1301502A1 Novel compounds and their use as glycine transport inhibitors
04/16/2003EP1301501A1 Tocotrienolquinone cyclisation product with an anti-hypercholesterol effect
04/16/2003EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use
04/16/2003EP1301498A1 Colchinol derivatives as angiogenesis inhibitors
04/16/2003EP1301497A1 Colchinol derivatives as vascular damaging agents
04/16/2003EP1301495A2 Inhibitors of copper-containing amine oxidases
04/16/2003EP1301493A2 Heterocycle carboxamides as antiviral agents
04/16/2003EP1301490A2 5-substituted 2-aryl-4-pyrimidinones
04/16/2003EP1301488A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
04/16/2003EP1301487A2 Viral polymerase inhibitors
04/16/2003EP1301486A2 Imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus
04/16/2003EP1301485A1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals
04/16/2003EP1301484A2 Capsaicin receptor ligands
04/16/2003EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists
04/16/2003EP1301481A1 Pyrrole derivatives for treating aids
04/16/2003EP1301480A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
04/16/2003EP1301479A2 STABILIZED 1$g(a)-HYDROXY VITAMIN D
04/16/2003EP1301476A1 New combination of serotonin agonist (5ht2) and antagonist (5ht6)as pharmaceutical formulation
04/16/2003EP1301475A1 Aryl sulfonamides as serotonin antagonist for the treatment of obesity
04/16/2003EP1301474A2 Tyrosine derivatives as phosphatase inhibitors
04/16/2003EP1301472A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
04/16/2003EP1301467A2 9-substituted minocycline compounds
04/16/2003EP1301466A2 7-substituted tetracycline compounds
04/16/2003EP1301465A2 13-substituted methacycline compounds
04/16/2003EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
04/16/2003EP1301463A1 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
04/16/2003EP1301460A1 Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry
04/16/2003EP1301226A2 Kits and compositions supporting intracranial perfusions
04/16/2003EP1301212A1 Pharmaceutically active compound
04/16/2003EP1301211A2 Multifunctional nanodevice platform
04/16/2003EP1301210A2 Compositions containing therapeutically active components having enhanced solubility
04/16/2003EP1301209A1 Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
04/16/2003EP1301207A2 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin
04/16/2003EP1301206A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate
04/16/2003EP1301203A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide
04/16/2003EP1301194A1 Essential oil combination and therapeutic uses thereof
04/16/2003EP1301193A1 Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof
04/16/2003EP1301192A1 Use of polysulphated cyclodextrins for treating osteoarthritis
04/16/2003EP1301191A1 Potent immunostimulants from microalgae
04/16/2003EP1301190A2 Pepsin inhibition by alginates
04/16/2003EP1301189A2 USE OF 2-METHYLENE-19-NOR-20(S)-1$g(a),25-DIHYDROXYVITAMIN D 3? TO INCREASE BONE STRENGTH
04/16/2003EP1301188A2 Anthelmintic agents for preventing parasitic infections in humans and animals iii
04/16/2003EP1301187A2 Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv
04/16/2003EP1301186A1 Sildenafil citrate solid dispersions having high water solubility
04/16/2003EP1301185A2 Anthelminthic agents for the prevention of parasitic infections in humans and animals
04/16/2003EP1301184A2 Valproic acid and derivatives thereof as histone deacetylase inhibitors
04/16/2003EP1301182A2 Use of matrix metalloprotease inhibitors for the treatment of cancer
04/16/2003EP1301181A2 Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
04/16/2003EP1301176A1 Method for coating solid particles with a thermofusible agent, and resulting coated solid particles
04/16/2003EP1301173A1 A medicinal aerosol formulation
04/16/2003EP1301168A1 Storage-stable compositions of glycerol monoalkyl ethers
04/16/2003EP1301150A1 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
04/16/2003EP1301077A2 Antimicrobial composition useful for the treatment of bovine mastitis
04/16/2003EP1301076A2 Enhancing therapeutic effectiveness of nitric oxide inhalation
04/16/2003EP1301074A2 Uses for nad synthetase inhibitors
04/16/2003EP1240159A4 Improved omeprazole process and compositions thereof
04/16/2003EP1218022B1 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
04/16/2003EP1185254B1 Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
04/16/2003EP1181017B1 Metalloprotease inhibitors
04/16/2003EP1173431B1 Method for the preparation of citalopram
04/16/2003EP1163224B1 N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance
04/16/2003EP1158967B1 Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix
04/16/2003EP1150981B1 Use of (1r, 4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol in hbv
04/16/2003EP1123093B1 Ubiquinone-containing composition suitable for promoting enhanced intramitochondrial transportation of ubiquinones and methods of using same
04/16/2003EP1121100B1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin
04/16/2003EP1102769B1 Tricyclic carboxamides
04/16/2003EP1100472B1 Pharmaceutical compositions comprising ibuprofen and domperidone
04/16/2003EP1096921B1 Liposomal encapsulated nucleic acid-complexes
04/16/2003EP1094812A4 Angiogenesis inhibitors
04/16/2003EP1094791B1 Thixotropic formulations for filling capsules
04/16/2003EP1090027B1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
04/16/2003EP1086682B1 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation
04/16/2003EP1083901B1 Efavirenz compressed tablet formulation
04/16/2003EP1075478B1 Phenylurea and phenylthio urea derivatives
04/16/2003EP1060187B1 S-substituted 11beta-benzaldoxime-estra-4,9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds
04/16/2003EP1056449B1 20-hete antagonists and agonists
04/16/2003EP1054667B1 Bicyclic pyrrole compounds, pharmaceutical compositions containing them and their use as antiinflammatory and immunomodulating agents
04/16/2003EP1053240B1 Glucocorticoid-selective antiinflammatory agents
04/16/2003EP1051156B1 Pharmaceutical compositions
04/16/2003EP1043986B1 Mixture and pharmaceutical composition comprising z-4-hydroxytamoxifen and cyclodextrin
04/16/2003EP1043981B1 Fat-binding polymers combined with lipase inhibitors for the treatment of obesity
04/16/2003EP1040095B1 Cyclohexene carboxylates as neuraminidase inhibitors
04/16/2003EP1028718B1 Extended release formulation containing venlafaxin
04/16/2003EP1026959B1 Method for increasing the concentration of conjugated linoleic acid in milk and/or tissue fat of a ruminant
04/16/2003EP1024807B1 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment
04/16/2003EP1023279B1 Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
04/16/2003EP1008588B1 11,15-o-dialkylprostaglandin e derivatives, process for producing the same, and drugs containing the same as the active ingredient
04/16/2003EP1007505B1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
04/16/2003EP0998451B1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
04/16/2003EP0994864B1 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic
1 ... 5500 5501 5502 5503 5504 5505 5506 5507 5508 5509 5510 5511 5512 5513 5514 5515 5516 5517 5518 5519 5520 ... 7860